Magnetic Resonance Imaging-Guided Laser Interstitial Thermal Therapy for Treatment of Drug-Resistant Epilepsy.
Publication/Presentation Date
1-1-2017
Abstract
Surgery is the most effective treatment for drug-resistant epilepsy. Long-term studies demonstrate that about 60% to 80% of patients become seizure-free after anterior temporal lobectomy and a majority of patients (about 95%) report significant seizure reduction after surgery. In the last few years, there has been significant advances in minimally invasive surgical techniques to treat drug-resistant epilepsy. These minimally invasive procedures have significant advantages over open surgery in that they produce less immediate discomfort and disability, while allowing for greater preservation of functional tissue. Laser interstitial thermal therapy (LiTT) is an example of such a procedure. Recent advances in imaging, surgical navigation, and real-time thermal monitoring have made LiTT safer and easier to implement, offering an effective and powerful neurosurgical tool for drug-resistant epilepsy. This article will review the technical considerations, uses, and potential future directions for LiTT in drug-resistant epilepsy.
Volume
14
Issue
1
First Page
176
Last Page
181
ISSN
1878-7479
Published In/Presented At
Kang, J. Y., & Sperling, M. R. (2017). Magnetic Resonance Imaging-Guided Laser Interstitial Thermal Therapy for Treatment of Drug-Resistant Epilepsy. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 14(1), 176–181. https://doi.org/10.1007/s13311-016-0498-3
Disciplines
Medicine and Health Sciences
PubMedID
27905093
Department(s)
Department of Medicine
Document Type
Article